Current problems in the use of the oncolytic drugs.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002648:Child; D002699:Chlorambucil / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000188:drug therapy; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008637:Mesenchymoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use; D013736:Testicular Neoplasms / Q000188:drug therapy; D014520:Urethane / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000188:drug therapy
D000970:Antineoplastic Agents; D012739:Gonadal Steroid Hormones; D006834:Hydrazines; D009588:Nitrogen Mustard Compounds; D013256:Steroids; D002699:Chlorambucil; D003609:Dactinomycin; D014520:Urethane; D014750:Vincristine; D014747:Vinblastine; D015122:Mercaptopurine; D002066:Busulfan; D005472:Fluorouracil; D008727:Methotrexate